Budget impact analysis guidelines : guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada.: H79-1/2007E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.689808&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board. |
|---|---|
| Title | Budget impact analysis guidelines : guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada. |
| Variant title | Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Later edition | Budget impact analysis guidelines : |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Lignes directrices pour l'analyse de l'incidence du prix d'un médicament : lignes directrices pour l'analyse de l'incidence du prix d'un médicament sur les budgets des régimes d'assurance-médicaments. "Published May 2007." Includes bibliographical references (pages 56-58). |
| Publishing information | [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2007. |
| Description | 1 online resource (i, 58 pages) |
| ISBN | 9780662458883 |
| Catalogue number |
|
| Edition | [First edition]. |
| Subject terms | Drugs -- Prices -- Canada. Drugs -- Economic aspects -- Canada. Pharmaceutical services insurance -- Canada. |